SALVATORE, DOMENICO
 Distribuzione geografica
Continente #
AS - Asia 3.942
EU - Europa 3.882
NA - Nord America 3.253
SA - Sud America 604
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 3
AN - Antartide 1
Totale 11.830
Nazione #
US - Stati Uniti d'America 3.113
SG - Singapore 2.237
RU - Federazione Russa 1.693
IT - Italia 1.057
CN - Cina 783
BR - Brasile 509
HK - Hong Kong 402
VN - Vietnam 252
DE - Germania 236
UA - Ucraina 195
FI - Finlandia 160
NL - Olanda 149
GB - Regno Unito 100
CA - Canada 94
IN - India 69
CI - Costa d'Avorio 56
FR - Francia 49
AR - Argentina 46
IE - Irlanda 45
ZA - Sudafrica 45
PL - Polonia 41
ES - Italia 37
SE - Svezia 32
MX - Messico 30
TR - Turchia 28
JP - Giappone 27
AT - Austria 25
BD - Bangladesh 24
KR - Corea 22
ID - Indonesia 18
EC - Ecuador 15
PK - Pakistan 15
IQ - Iraq 14
BE - Belgio 11
UZ - Uzbekistan 10
LT - Lituania 8
PY - Paraguay 8
SK - Slovacchia (Repubblica Slovacca) 8
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
DZ - Algeria 6
EG - Egitto 6
CZ - Repubblica Ceca 5
DK - Danimarca 5
HN - Honduras 5
KE - Kenya 5
MA - Marocco 5
UY - Uruguay 5
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
CL - Cile 3
EU - Europa 3
SN - Senegal 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IL - Israele 2
KW - Kuwait 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AQ - Antartide 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
Totale 11.817
Città #
Singapore 996
Moscow 405
Hong Kong 399
Naples 346
Ashburn 299
Chandler 259
Beijing 245
Jacksonville 178
Santa Clara 161
Hefei 133
Amsterdam 125
Millbury 105
Los Angeles 103
Ho Chi Minh City 102
Napoli 92
Boston 84
Munich 78
Princeton 77
Buffalo 65
New York 63
Nanjing 54
Wilmington 51
São Paulo 48
Turku 48
Ottawa 43
Redondo Beach 40
Lawrence 39
Dallas 36
Hanoi 35
Des Moines 34
Warsaw 32
Orem 28
Helsinki 25
Brooklyn 24
Nuremberg 24
Salerno 23
Stockholm 23
Chicago 22
Montreal 22
Seattle 22
Seoul 22
Johannesburg 20
Kochi 20
Rome 20
Norwalk 19
Phoenix 19
Poplar 19
San Giovanni Rotondo 19
Hebei 17
Houston 17
Shenyang 17
The Dalles 17
Dong Ket 16
Milan 16
Frankfurt am Main 15
Mexico City 15
Nanchang 15
Chennai 14
Belo Horizonte 13
Tokyo 13
Washington 13
Afragola 12
Ann Arbor 12
Florence 12
Okayama 12
Rio de Janeiro 12
Santa Maria 12
Santa Maria Capua Vetere 12
Denver 11
Haiphong 11
Ottaviano 11
San Francisco 11
Tianjin 11
Toronto 11
Atlanta 10
Aversa 10
Curitiba 10
London 10
Vienna 10
Avellino 9
Casoria 9
Changsha 9
Lappeenranta 9
Ankara 8
Bratislava 8
Formia 8
Jiaxing 8
Kronberg 8
Menlo Park 8
Orta di Atella 8
Porto Alegre 8
Roubaix 8
Steamboat Springs 8
Tashkent 8
Woodbridge 8
Augusta 7
Biên Hòa 7
Brasília 7
Fairfield 7
Falkenstein 7
Totale 5.711
Nome #
Spot-light on microbiota in obesity and cancer 177
Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch 169
The thyroid hormone activating enzyme, type 2 deiodinase, induces myogenic differentiation by regulating mitochondrial metabolism and reducing oxidative stress 160
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage 155
Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis 153
Deiodinases and their intricate role in thyroid hormone homeostasis 149
D898_E901 RET Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms 148
The Concerted Action of Type 2 and Type 3 Deiodinases Regulates the Cell Cycle and Survival of Basal Cell Carcinoma Cells 144
Exposure to artificial light at night: A common link for obesity and cancer? 143
Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling 142
Thyroid hormone enhances angiogenesis and the warburg effect in squamous cell carcinomas 135
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 131
Type 2 deiodinase is expressed in anaplastic thyroid carcinoma and its inhibition causes cell senescence 130
Beta-Catenin Regulates Deiodinase Levels and Thyroid Hormone Signaling in Colon Cancer Cells 130
Vandetanib downregulates type 2 deiodinase in fibro/adipogenic progenitors 129
DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient patients 129
Calcium interaction with bovine Thyroglobulin: Stoichiometry and structural consequences of calcium binding. 125
Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences 125
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 121
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 116
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 116
Author Correction: Thyroid hormone induces progression and invasiveness of squamous cell carcinomas by promoting a ZEB-1/E-cadherin switch (Nature Communications, (2019), 10, 1, (5410), 10.1038/s41467-019-13140-2) 115
Type 2 Deiodinase Promotes Fatty Adipogenesis in Muscle Fibroadipogenic Progenitors From Adult Male Mice 111
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 109
Advances in functional imaging of differentiated thyroid cancer 109
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 108
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 108
Mice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced hepatonecrosis. 107
Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression 107
Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis 106
Type 3 deiodinase and solid tumors: an intriguing pair. 106
Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation 105
Management of one patient with oligoprogressive thyroid cancer during treatment with lenvatinib 105
A Type 2 Deiodinase-Dependent Increase in Vegfa Mediates Myoblast-Endothelial Cell Crosstalk during Skeletal Muscle Regeneration 105
Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results 104
Calcium interaction with bovine thyroiglobulin: stoichiometry and structural consequences of calcium binding 104
Germ Line Mutations in the Thyroid Hormone Receptor Alpha Gene Predispose to Cutaneous Tags and Melanocytic Nevi 102
Identification and functional characterization of a novel mutation in the NKX2-1 gene: Comparison with the data in the literature 101
Epigenetic control of type 2 and 3 deiodinases in myogenesis: role of Lysine-specific Demethylase enzyme and FoxO3 100
Local ablative therapy of oligoprogressive TKI-treated thyroid cancer 100
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 99
Thyroid hormone signaling and deiodinase actions in muscle stem/progenitor cells 99
The importance of the RET gene in thyroid cancer and therapeutic implications 99
Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. 98
Methods and Products for Treating Proliferative Disorders. 97
The selective loss of the Type 2 iodothyronine deiodinase in mouse thyrotrophs increases basal TSH but blunts the thyrotropin response to hypothyroidism 97
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 97
Thyroid hormone action in muscle atrophy 97
Teriparatide replacement therapy for hypoparathyroidism during treatment with lenvatinib for advanced thyroid cancer: A case report 96
Endemic goiter and iodine deficiency diffusion in province of Avellino 95
A Global Loss of Dio2 Leads to Unexpected Changes in Function and Fiber Types of Slow Skeletal Muscle in Male Mice 95
Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer 95
The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. 94
Transcription factor Nkx-2.5 induces sodium/iodidesymporter gene expression and participates in retinoic acid- andlactation-induced transcription in mammary cells. 94
p63 control of desmosome gene expression and adhesion is compromised in AEC syndrome 93
Identification and Functional Characterization of a Novel Mutation in theNKX2-1Gene: Comparison with the Data in the Literature 91
Widespread endemic goiter and iodine deficiency in the province of Avellino 90
The relevance of T3 in the management of hypothyroidism 90
Tiroide è Donna 89
CHERACTERIZATION OF THE 5'-FLANKING AND 5'UNTRANSLATED REGIONS OF THE CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE-RESPONSIVE HUMAN TYPE 2 DEIODINASE GENE. 87
The different cardiac expression of the Type 2 Iodothyronine deiodinase gene between human and rat is related to the differential response of the dio2 genes to NKX-2.5 and GATA-4 transcription factors 87
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins. 87
APPROCCIO CLINICO AL PAZIENTE CON GOZZO 86
On the governance of incentives to innovate: Can Open Source models be applied to drug development? 86
FT3 and FT3/FT4 ratio are decreased and not compensated by levothyroxine treatment in TKI-treated thyroid cancer patients 85
CLONING OF THE RAT TISSUE INHIBITOR OF METALLOPROTEINASE TYPE 2 (timp-2) GENE; ANALYSIS OF ITSEXPRESSION IN NORMAL AND TRASFORMED THYROID CELLS. 85
Deiodination in cancer growth: the role of type III deiodinase 85
Type 2 Iodothyronine Deiodinase Levels Are Higher in Slow-Twitch than Fast-Twitch Mouse Skeletal Muscle and Are Increased in Hypothyroidism 85
Role of type 3 deiodinase in cancer. 85
Elexacaftor–tezacaftor–ivacaftor therapy for cystic fibrosis patients with the f508del/unknown genotype 85
Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back 85
Biochemistry, cellular and molecular biology, and physiological role of the iodothyronine selenodeiodinases 84
Enhanced adrenal renin and aldosterone biosynthesis during sodium restriction in TGR (mREN2)27 rats 83
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? 82
PTC IN THYROID TUMORS 82
A 21 year old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase 82
Deiodinases in thyroid tumorigenesis 82
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 81
Consumptive hypothyroidism resulting from hepatic vascular tumors in an athyreotic adult. 79
Deiodinases and Cancer 78
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer 78
The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. 78
RET\PTC activation in human thyroid carcinomas 77
Development of mammary and cutaneous gland tumors in transgenic mice carrying the RET/PTC1 oncogene. 77
Type II iodothyronine deiodinase provides intracellular 3,5,3'-triiodothyronine to normal and regenerating mouse skeletal muscle 76
Pendrin is a Novel In Vivo Downstream Target Gene of the TTF-1/Nkx-2.1 Homeodomain Transcription Factor in Differentiated Thyroid Cells 76
FREQUENT RET PROTO-ONCOGENE MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (MEN2A). 75
DEVELOPMENT OF MAMMARY AND CUTANEOUS GLAND TUMORS IN TRANSGENIC MICE CARRYNG THE Ret/Ptc 1 ONCOGENE. 74
Effectivenesss of ivacaftor in severe cystic fibrosis patients and non-G551D gating mutations 74
MUTATION OF SECYS RESIDUE 266 IN HUMAN D2 SELENODEIODINASE ALTERS 75Se INCORPORATION WITHOUT AFFECTING THE BIOCHEMICAL PROPERTIES. 73
Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. 73
INCREASED IN-VIVO PHOSPHORILATION OF RET TYROSINE 1062 IS A POTENTIAL PATHOGENETIC MECHANISM OF MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B. 72
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 72
Pre-translational regulation of type 2 deiodinase 71
Development of thyroid papillary carcinomas secondary to tissue specific expression of the RET/PTC1 oncogene in transgenic mice 71
Tyrosines 1015 and 1062 are in vivo auto-phosphorylation site in Ret and Ret-derived oncoproteins 70
THE GUANOSINE MONOPHOSPHATE REDUCTASE GENE IS CONSERVED IN RATS AND ITS EXPRESSION INCREASES RAPIDLY IN BROWN ADIPOSE TISSUE DURING COLD EXPOSURE. 68
THE HUMAN TYPE 2 IODOTHYRONINE DEIODINASE IS A SELENOPROTEIN HIGHLY EXPRESSED IN A MESOTHELIOMA CELL LINE. 68
MOLECULAR BIOLOGICAL AND BIOCHEMICAL CHARACTERIZATION OF THE HUMAN TYPE 2 SELENODEIODINASE. 67
TYPE 3 IODOTHYRONINE DEIDINASE CLONING, IN VITRO EXPRESSION, AND FUNCTIONAL ANALYSIS OF THE PLACENTAL SELENOENZYME. 67
Totale 9.962
Categoria #
all - tutte 39.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 0 0 51 44 30 50 16 54 17
2021/2022833 14 61 33 23 21 12 36 23 70 55 217 268
2022/2023846 125 71 24 27 81 72 7 59 137 129 60 54
2023/2024821 50 128 152 71 48 69 16 78 26 18 110 55
2024/20253.999 200 250 33 39 107 239 433 224 295 403 1.386 390
2025/20264.261 874 476 734 791 1.202 184 0 0 0 0 0 0
Totale 12.026